Certara announces expansion of clinical technology collaboration with merck

Radnor, pa., july 08, 2025 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, today announced a new collaboration with merck, known as msd outside of the united states and canada, that expands merck's use of the certara pinnacle 21 software platform to include a metadata repository and data standards workflow management.

CERT Ratings Summary

CERT Quant Ranking